CLOMIPRAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Clomipramine patents expire, and what generic alternatives are available?
Clomipramine is a drug marketed by Ajanta Pharma Ltd, Alembic, Amneal Pharms Co, Aurobindo Pharma, Chartwell Rx, Ixora Lifescience, Jubilant Cadista, Lupin, Mankind Pharma, Micro Labs, Pharmobedient, Rk Pharma, Sandoz, Taro, Teva, Tp Anda Holdings, Unique, Watson Labs, and Zydus Pharms. and is included in twenty-one NDAs.
The generic ingredient in CLOMIPRAMINE is clomipramine hydrochloride. There are eleven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the clomipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clomipramine
A generic version of CLOMIPRAMINE was approved as clomipramine hydrochloride by CHARTWELL RX on March 29th, 1996.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CLOMIPRAMINE?
- What are the global sales for CLOMIPRAMINE?
- What is Average Wholesale Price for CLOMIPRAMINE?
Summary for CLOMIPRAMINE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 21 |
| Drug Prices: | Drug price information for CLOMIPRAMINE |
| DailyMed Link: | CLOMIPRAMINE at DailyMed |
US Patents and Regulatory Information for CLOMIPRAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 074694-002 | Dec 31, 1996 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmobedient | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 074947-002 | Apr 30, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Tp Anda Holdings | CLOMIPRAMINE HYDROCHLORIDE | clomipramine hydrochloride | CAPSULE;ORAL | 210653-001 | Apr 3, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
